Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated Charcoal Feasibility in Healthy Volunteers
NCT04204772Phase 1Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jan 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of activated charcoal in dysbiosis (4 arms), sponsored by Masonic Cancer Center. Primary endpoint: Average Palatability Rating at 2 weeks. Started Jan 2020; status: completed.
02
Drugs
activated charcoal
03
Conditions
dysbiosis
Beyond the preview
Go deeper on NCT04204772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04204772.